• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清骨硬化蛋白和护骨素水平与急性心肌梗死患者的存在、严重程度和预后的关系。

Association of serum sclerostin and osteoprotegerin levels with the presence, severity and prognosis in patients with acute myocardial infarction.

机构信息

Department of Cardiovascular Medicine, The Third Affiliated Hospital, SunYat-Sen University, No. 600, Tianhe Road, Guangzhou, 510630, China.

Department of Cardiac Care Unit, The Third Affiliated Hospital, SunYat-Sen University, Guangzhou, China.

出版信息

BMC Cardiovasc Disord. 2022 May 11;22(1):213. doi: 10.1186/s12872-022-02654-1.

DOI:10.1186/s12872-022-02654-1
PMID:35546224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9092859/
Abstract

BACKGROUND

Bone-related proteins (such as sclerostin and osteoprotegerin [OPG]) are involved in the development of atherosclerosis. However, the relationship between bone-related proteins and acute myocardial infarction (AMI) has not been extensively evaluated. The purpose of this study was to assess the association of serum sclerostin and OPG with the presence, severity and prognosis in patients with AMI.

METHODS

This study prospectively enrolled 152 patients attacked by acute chest pain. Serum sclerostin and OPG were detected within the first 24 h after AMI diagnosis by ELISA kits. The AMI predictive efficacy of sclerostin and OPG were analyzed by receiver operating characteristics (ROC) curve. Univariable and multivariable linear regression analyses were performed to determine the association between bone-related proteins and scores indicating the severity of coronary artery occlusion. Moreover, prognostic values were assessed by Kaplan-Meier curves and Cox regression analysis.

RESULTS

There were 92 patients in AMI group, 60 in non-AMI group. Serum levels of sclerostin and OPG were significantly higher in AMI group than in non-AMI group (all p < 0.001), which showed predictive value for the presence of AMI (all p < 0.001). The area under the ROC curve values of sclerostin and OPG were 0.744 and 0.897, respectively. A multivariable linear regression analysis demonstrated that Ln-transformed sclerostin (β = 0.288, p = 0.009) and Ln-transformed OPG (Ln-OPG: β = 0.295, p = 0.019) levels were associated with GENISINI score, independently of conventional clinical parameters. In addition, Ln-OPG levels were still positively associated with GRACE score after adjustments (β = 0.320, p = 0.001). During a 1-year follow-up, patients above the median of sclerostin levels had higher incidence of major adverse cardiac events (MACE) than those below the median (p = 0.028). It was also observed that the MACE rates were higher in patients above the median of OPG levels, though no statistic importance (p = 0.060). After adjusting conventional risk factors by multivariate Cox regression, Ln-OPG was associated with incident MACE (hazard ratio = 2.188 [95% confidence intervals 1.102-4.344], p = 0.025).

CONCLUSIONS

Bone-related proteins could exert a potential role in early risk stratification and prognosis assessment in patients with AMI.

摘要

背景

骨相关蛋白(如硬化蛋白和骨保护素[OPG])参与动脉粥样硬化的发生。然而,骨相关蛋白与急性心肌梗死(AMI)之间的关系尚未得到广泛评估。本研究旨在评估血清硬化蛋白和 OPG 与 AMI 患者的存在、严重程度和预后的关系。

方法

本研究前瞻性纳入了 152 例因急性胸痛就诊的患者。采用 ELISA 试剂盒在 AMI 诊断后 24 小时内检测血清硬化蛋白和 OPG。通过受试者工作特征(ROC)曲线分析硬化蛋白和 OPG 的 AMI 预测效能。采用单变量和多变量线性回归分析来确定骨相关蛋白与冠状动脉闭塞严重程度评分之间的关系。此外,通过 Kaplan-Meier 曲线和 Cox 回归分析评估预后价值。

结果

AMI 组 92 例,非 AMI 组 60 例。AMI 组血清硬化蛋白和 OPG 水平明显高于非 AMI 组(均 p<0.001),对 AMI 的存在具有预测价值(均 p<0.001)。ROC 曲线下面积值显示硬化蛋白和 OPG 的 AUC 值分别为 0.744 和 0.897。多变量线性回归分析表明,Ln 转化的硬化蛋白(β=0.288,p=0.009)和 Ln 转化的 OPG(Ln-OPG:β=0.295,p=0.019)水平与 GENISINI 评分独立相关,不受常规临床参数的影响。此外,调整后 Ln-OPG 水平仍与 GRACE 评分呈正相关(β=0.320,p=0.001)。在 1 年随访期间,硬化蛋白水平中位数以上的患者发生主要不良心脏事件(MACE)的发生率高于中位数以下的患者(p=0.028)。虽然没有统计学意义(p=0.060),但也观察到 OPG 水平中位数以上的患者 MACE 发生率更高。多变量 Cox 回归调整常规危险因素后,Ln-OPG 与 MACE 事件相关(危险比=2.188[95%置信区间 1.102-4.344],p=0.025)。

结论

骨相关蛋白可能在 AMI 患者的早期风险分层和预后评估中发挥潜在作用。

相似文献

1
Association of serum sclerostin and osteoprotegerin levels with the presence, severity and prognosis in patients with acute myocardial infarction.血清骨硬化蛋白和护骨素水平与急性心肌梗死患者的存在、严重程度和预后的关系。
BMC Cardiovasc Disord. 2022 May 11;22(1):213. doi: 10.1186/s12872-022-02654-1.
2
Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.ST 段抬高型心肌梗死中的骨保护素:预后影响及与磁共振成像心肌损伤标志物的相关性。
Int J Cardiol. 2013 Sep 1;167(5):2134-9. doi: 10.1016/j.ijcard.2012.05.101. Epub 2012 Jun 15.
3
Sclerostin and osteoprotegerin: new markers of chronic kidney disease mediated mineral and bone disease in children.骨硬化蛋白和护骨素:儿童慢性肾脏病相关矿物质和骨疾病的新标志物。
J Pediatr Endocrinol Metab. 2020 Nov 26;33(11):1383-1390. doi: 10.1515/jpem-2020-0140.
4
The Value of Combined Detection of Serum BNP, Cardiac Troponin-I and Dynamic Electrocardiogram in Early Clinical Diagnosis and Prognosis of Patients with Acute Myocardial Infarction.血清 BNP、心肌肌钙蛋白 I 与动态心电图联合检测在急性心肌梗死患者早期临床诊断及预后评估中的价值。
Discov Med. 2024 Mar;36(182):598-603. doi: 10.24976/Discov.Med.202436182.56.
5
Serum IGFBP5 as a predictor of major adverse cardiac events in patients with acute myocardial infarction.血清 IGFBP5 可预测急性心肌梗死患者的主要不良心脏事件。
Int J Cardiol. 2024 Sep 15;411:132268. doi: 10.1016/j.ijcard.2024.132268. Epub 2024 Jun 14.
6
Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction.微血管功能障碍与急性心肌梗死患者的血浆骨保护素水平相关。
Coron Artery Dis. 2013 Sep;24(6):487-92. doi: 10.1097/MCA.0b013e328363242e.
7
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction.骨保护素在急性心肌梗死后心力衰竭中的预后价值。
J Am Coll Cardiol. 2004 Nov 16;44(10):1970-6. doi: 10.1016/j.jacc.2004.06.076.
8
Usefulness of the CHADS2 score for prognostic stratification of patients with acute myocardial infarction.CHADS2评分对急性心肌梗死患者预后分层的实用性。
Am J Cardiol. 2014 Nov 1;114(9):1309-14. doi: 10.1016/j.amjcard.2014.07.063. Epub 2014 Aug 12.
9
Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction.急性心肌梗死后血清花生四烯酸和二十碳五烯酸水平与主要不良心脏事件发生率的关联
Heart Vessels. 2011 Mar;26(2):145-52. doi: 10.1007/s00380-010-0038-8. Epub 2010 Oct 21.
10
Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.生长分化因子 15 和骨保护素在急性心肌梗死并发心源性休克中的变化:IABP-SHOCK II 试验的生物标志物亚研究。
Eur J Heart Fail. 2014 Aug;16(8):880-7. doi: 10.1002/ejhf.117. Epub 2014 Jun 5.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
The role of the osteoprotegerin/RANKL/RANK axis and osteopontin in acute coronary syndrome.骨保护素/核因子κB受体活化因子配体/核因子κB受体活化因子轴及骨桥蛋白在急性冠状动脉综合征中的作用
Arch Cardiol Mex. 2024 May 29;95(1):1-8. doi: 10.24875/ACM.24000037.
3
Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction.

本文引用的文献

1
Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction.ST 段抬高型心肌梗死患者入院时高敏肌钙蛋白的预后价值。
Heart. 2021 Dec;107(23):1881-1888. doi: 10.1136/heartjnl-2021-319225. Epub 2021 Sep 20.
2
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases.骨保护素和 RANKL-RANK-OPG-TRAIL 信号轴在心力衰竭和其他心血管疾病中的作用。
Heart Fail Rev. 2022 Jul;27(4):1395-1411. doi: 10.1007/s10741-021-10153-2. Epub 2021 Jul 27.
3
Atherosclerosis and Bone Loss in Humans-Results From Deceased Donors and From Patients Submitted to Carotid Endarterectomy.
ST 段抬高型心肌梗死与非 ST 段抬高型心肌梗死的差异基因表达模式。
Sci Rep. 2024 Feb 10;14(1):3424. doi: 10.1038/s41598-024-54086-w.
4
Causal effects for genetic variants of osteoprotegerin on the risk of acute myocardial infarction and coronary heart disease: A two-sample Mendelian randomization study.骨保护素基因变异对急性心肌梗死和冠心病风险的因果效应:一项两样本孟德尔随机化研究。
Front Cardiovasc Med. 2023 Mar 7;10:1041231. doi: 10.3389/fcvm.2023.1041231. eCollection 2023.
5
Correlation between osteoprotegerin and coronary artery calcification in diabetic subjects: a systematic review of observational studies.骨保护素与糖尿病患者冠状动脉钙化的相关性:观察性研究的系统评价。
BMC Cardiovasc Disord. 2023 Feb 21;23(1):96. doi: 10.1186/s12872-023-03123-z.
人类动脉粥样硬化与骨质流失——来自已故捐赠者及接受颈动脉内膜切除术患者的研究结果
Front Med (Lausanne). 2021 May 20;8:672496. doi: 10.3389/fmed.2021.672496. eCollection 2021.
4
The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up.硬化素水平对接受冠状动脉造影患者长期预后的影响:一项为期9年随访的个性化研究
J Pers Med. 2021 Mar 6;11(3):186. doi: 10.3390/jpm11030186.
5
Sclerostin: from bench to bedside.硬化素:从实验室到临床应用
J Bone Miner Metab. 2021 May;39(3):332-340. doi: 10.1007/s00774-020-01176-0. Epub 2020 Nov 18.
6
Association of serum sclerostin levels with atherosclerosis severity in patients referred for invasive coronary angiography.接受有创冠状动脉造影检查患者的血清硬化素水平与动脉粥样硬化严重程度的关联。
Kardiol Pol. 2020 Dec 23;78(12):1271-1273. doi: 10.33963/KP.15622. Epub 2020 Sep 25.
7
Use of cardiac troponin in the early diagnosis of acute myocardial infarction.心肌钙蛋白在急性心肌梗死早期诊断中的应用。
Kardiol Pol. 2020 Nov 25;78(11):1099-1106. doi: 10.33963/KP.15585. Epub 2020 Aug 25.
8
Sclerostin and Vascular Pathophysiology.骨硬化蛋白与血管病理生理学。
Int J Mol Sci. 2020 Jul 6;21(13):4779. doi: 10.3390/ijms21134779.
9
Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology.骨源性激素在 2 型糖尿病和心血管病理生理学中的作用。
Mol Metab. 2020 Oct;40:101040. doi: 10.1016/j.molmet.2020.101040. Epub 2020 Jun 13.
10
Association of sclerostin with cardiovascular events and mortality in dialysis patients.硬骨素与透析患者心血管事件和死亡的相关性。
Ren Fail. 2020 Nov;42(1):282-288. doi: 10.1080/0886022X.2020.1741386.